Schultheis K H, Schulz A, Schiefer H G
Unfallchirurgie. 1981 Dec;7(6):324-33. doi: 10.1007/BF02592973.
Report about an aminoacid, which hardens quickly in liquid environment. It is highly suitable as carrier of chemotherapeutic agents. In-vitro tests show an antibiotic inhibitory activity of different compounds for at least 41 days. According to in-vivo experiments in 17 rats the new substance is replaced in the bone and in soft tissues by fibrous tissue; the antibiotic activity is released slowly. This offers a new carrier which is suitable for occlusion of cavities. The instillation of the new amino-acid (Ethibloc) combined with antibiotics could be a new treatment for chronic osteomyelitis.
关于一种在液体环境中迅速硬化的氨基酸的报告。它非常适合作为化疗药物的载体。体外试验表明,不同化合物的抗生素抑制活性至少持续41天。根据对17只大鼠的体内实验,新物质在骨骼和软组织中被纤维组织取代;抗生素活性缓慢释放。这提供了一种适用于封堵腔隙的新载体。将新氨基酸(Ethibloc)与抗生素联合滴注可能是慢性骨髓炎的一种新治疗方法。